Entera Bio LTD Form 4 insider transactions

Director Gerald M. Ostrov of Entera Bio Ltd. received shares and stock options as compensation for board service and an annual grant.

Director Yonatan Malca receives stock options and shares from Entera Bio in lieu of cash fees and as an annual grant.

Entera Bio director Gerald M. Lieberman received shares and stock options as compensation for board service in the fourth quarter of 2024.

Director Sean Ellis receives shares and options from Entera Bio in lieu of cash fees and as an annual grant.

Director Haya Taitel reports acquiring and disposing of Entera Bio shares on October 2, 2024.

Director Gerald Ostrov reports acquiring 8,452 Entera Bio shares and disposing of 38,898 shares in a recent transaction.

Director Yonatan Malca reports acquiring and disposing of Entera Bio shares on October 2, 2024.

Director Gerald Lieberman reported acquiring and disposing of Entera Bio shares on October 2, 2024, along with indirect ownership through several trusts.

Director Sean Ellis reports acquisition of 7,466 shares and disposal of 127,627 shares of Entera Bio Ltd. on October 2, 2024.

Director Gerald Ostrov reports acquiring 20,446 Entera Bio shares and disposing of 30,446 shares in a recent transaction.

Director Haya Taitel reports acquisition and disposal of Entera Bio shares on August 27, 2024.

Director Sean Ellis reports acquiring and disposing of Entera Bio shares on August 27, 2024.

Director Yonatan Malca reports acquiring and disposing of Entera Bio shares in a recent transaction.

Director Gerald Lieberman reports acquiring 27,261 shares and disposing of 254,222 shares of Entera Bio Ltd. on August 27, 2024.

Dana Yaacov-Garbeli, CFO of Entera Bio Ltd., received stock options and restricted stock units, and an amendment was filed to correct a previous reporting error regarding direct ownership.

Entera Bio's CEO, Miranda Jayne Toledano, reports the acquisition of stock options and restricted stock units after shareholder approval on July 31, 2024.

Dana Yaacov-Garbeli, CFO of Entera Bio Ltd., reports the acquisition of stock options and restricted stock units.

Hillel Galitzer, Chief Operating Officer of Entera Bio Ltd., reports acquisition of restricted stock units and stock options, as well as disposal of ordinary shares.